IMC Chicago
CRSP icon

IMC Chicago’s CRISPR Therapeutics CRSP Stock Holding History

IMC Chicago’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$584K Buy
+10,709
New +$564K ﹤0.01% 4463
2025
Q3 		– Sell
-23,080
Closed -$1.33M – 3649
2025
Q2 		$1.12M Sell
23,080
-39,134
-63% -$1.51M ﹤0.01% 2400
2025
Q1 		$2.12M Sell
62,214
-24,255
-28% -$1.03M ﹤0.01% 1768
2024
Q4 		$3.4M Buy
+86,469
New +$4.08M ﹤0.01% 1484
2024
Q2 		– Sell
-36,722
Closed -$2.12M – 2649
2024
Q1 		$2.5M Sell
36,722
-1,495
-4% -$107K ﹤0.01% 1257
2023
Q4 		$2.39M Buy
38,217
+6,914
+22% +$382K ﹤0.01% 1146
2023
Q3 		$1.42M Buy
31,303
+15,640
+100% +$808K ﹤0.01% 1102
2023
Q2 		$879K Buy
15,663
+1,731
+12% +$98.2K ﹤0.01% 1087
2023
Q1 		$630K Sell
13,932
-6,974
-33% -$339K ﹤0.01% 1135
2022
Q4 		$850K Buy
+20,906
New +$1.11M ﹤0.01% 1036
2022
Q2 		– Sell
-21,994
Closed -$1.29M – 1075
2022
Q1 		$1.38M Sell
21,994
-24,086
-52% -$1.51M ﹤0.01% 839
2021
Q4 		$3.49M Buy
46,080
+18,036
+64% +$1.58M ﹤0.01% 688
2021
Q3 		$3.14M Buy
28,044
+15,291
+120% +$1.92M ﹤0.01% 734
2021
Q2 		$2.06M Sell
12,753
-7,667
-38% -$932K ﹤0.01% 775
2021
Q1 		$2.49M Buy
+20,420
New +$3.08M ﹤0.01% 702

Other funds holding CRSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

IMC Chicago's CRSP Position: Q2 2026 in Review

IMC Chicago opened a new position in CRISPR Therapeutics (CRSP) in Q2 2026: 10,709 shares worth $584K. The stake represents ﹤0.01% of the portfolio and ranks #4463 among its holdings. This is a return to the name: IMC Chicago previously reported a position in CRSP as recently as Q2 2025.

IMC Chicago first reported a position in CRSP in Q1 2021 and has held it in 15 quarters since. The position peaked at $3.49M in Q4 2021. 292 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • IMC Chicago held 10,709 shares of CRISPR Therapeutics worth $584K as of Q2 2026.
  • CRISPR Therapeutics was a new IMC Chicago position in Q2 2026.
  • CRISPR Therapeutics made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #4463 holding.
  • IMC Chicago first reported a position in CRISPR Therapeutics in Q1 2021 and has held it in 15 quarters since.
  • IMC Chicago's CRISPR Therapeutics position peaked at $3.49M in Q4 2021.
  • 292 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.